AU2008253977B2 - A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease - Google Patents

A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease Download PDF

Info

Publication number
AU2008253977B2
AU2008253977B2 AU2008253977A AU2008253977A AU2008253977B2 AU 2008253977 B2 AU2008253977 B2 AU 2008253977B2 AU 2008253977 A AU2008253977 A AU 2008253977A AU 2008253977 A AU2008253977 A AU 2008253977A AU 2008253977 B2 AU2008253977 B2 AU 2008253977B2
Authority
AU
Australia
Prior art keywords
salt
donepezil
disease
medicament
treating alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008253977A
Other languages
English (en)
Other versions
AU2008253977A1 (en
Inventor
Heii Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Juntendo University
Original Assignee
Otsuka Pharmaceutical Co Ltd
Juntendo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Juntendo University filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2008253977A1 publication Critical patent/AU2008253977A1/en
Application granted granted Critical
Publication of AU2008253977B2 publication Critical patent/AU2008253977B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2008253977A 2007-05-22 2008-05-21 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease Ceased AU2008253977B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22
JP2007-135367 2007-05-22
PCT/JP2008/059763 WO2008143361A1 (en) 2007-05-22 2008-05-21 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease

Publications (2)

Publication Number Publication Date
AU2008253977A1 AU2008253977A1 (en) 2008-11-27
AU2008253977B2 true AU2008253977B2 (en) 2013-08-22

Family

ID=39636992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008253977A Ceased AU2008253977B2 (en) 2007-05-22 2008-05-21 A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease

Country Status (27)

Country Link
US (1) US20100298375A1 (https=)
EP (2) EP2937085B1 (https=)
JP (1) JP5153870B2 (https=)
KR (1) KR101441725B1 (https=)
CN (1) CN101754758B (https=)
AR (1) AR066664A1 (https=)
AU (1) AU2008253977B2 (https=)
BR (1) BRPI0811919A2 (https=)
CA (1) CA2687289C (https=)
CO (1) CO6251249A2 (https=)
CY (1) CY1116683T1 (https=)
DK (1) DK2157973T3 (https=)
ES (1) ES2545959T3 (https=)
HR (1) HRP20150843T1 (https=)
HU (1) HUE025902T2 (https=)
IL (1) IL202053A (https=)
MX (1) MX2009012583A (https=)
MY (1) MY146407A (https=)
NZ (1) NZ581099A (https=)
PL (1) PL2157973T3 (https=)
PT (1) PT2157973E (https=)
RU (1) RU2469723C2 (https=)
SI (1) SI2157973T1 (https=)
TW (2) TWI489983B (https=)
UA (1) UA96633C2 (https=)
WO (1) WO2008143361A1 (https=)
ZA (1) ZA200908202B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
TR201809351T4 (tr) 2011-03-01 2018-07-23 Pharnext Nörolojik bozuklukların baklofen ve akamprosat tabanlı terapisi.
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
KR20150027800A (ko) * 2012-06-15 2015-03-12 고에키 자이단 호징 센탄 이료 신코 자이단 경도 인지 장해의 예방 및/또는 치료제
WO2015100255A2 (en) * 2013-12-23 2015-07-02 Holaday John W Disposable container for air hydration
WO2017199755A1 (ja) * 2016-05-19 2017-11-23 国立研究開発法人国立循環器病研究センター 認知症の予防及び／又は治療のための薬剤
MX385719B (es) 2017-05-24 2025-03-18 H Lundbeck As Combinacion de un antagonista del receptor 5-ht6 y un inhibidor de acetilcolinesterasa para su uso en el tratamiento de la enfermedad de alzheimer en una subpoblacion de pacientes portadores de alelos apoe4
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229913A1 (en) * 2002-12-13 2004-11-18 Eisal Co., Ltd. Therapeutic agent for severe Alzheimer's dementia

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
EP1047674B1 (en) * 1998-01-16 2005-03-30 Eisai Co., Ltd. Process for production of donepezil derivatives
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040229913A1 (en) * 2002-12-13 2004-11-18 Eisal Co., Ltd. Therapeutic agent for severe Alzheimer's dementia

Also Published As

Publication number Publication date
RU2469723C2 (ru) 2012-12-20
DK2157973T3 (en) 2015-08-17
SI2157973T1 (sl) 2015-10-30
TW201412315A (zh) 2014-04-01
CA2687289A1 (en) 2008-11-27
IL202053A0 (en) 2010-06-16
HK1140422A1 (en) 2010-10-15
EP2157973B1 (en) 2015-07-15
HK1215384A1 (en) 2016-08-26
PL2157973T3 (pl) 2015-12-31
HUE025902T2 (en) 2016-05-30
TW200904428A (en) 2009-02-01
ES2545959T3 (es) 2015-09-17
JP5153870B2 (ja) 2013-02-27
PT2157973E (pt) 2015-10-14
HRP20150843T1 (hr) 2015-09-11
CO6251249A2 (es) 2011-02-21
EP2937085B1 (en) 2019-07-10
ZA200908202B (en) 2010-07-28
CN101754758B (zh) 2012-10-24
US20100298375A1 (en) 2010-11-25
UA96633C2 (uk) 2011-11-25
IL202053A (en) 2016-04-21
CA2687289C (en) 2015-09-15
EP2157973A1 (en) 2010-03-03
AU2008253977A1 (en) 2008-11-27
CY1116683T1 (el) 2017-03-15
WO2008143361A1 (en) 2008-11-27
TWI489983B (zh) 2015-07-01
NZ581099A (en) 2012-03-30
BRPI0811919A2 (pt) 2014-11-18
MX2009012583A (es) 2010-03-08
MY146407A (en) 2012-08-15
AR066664A1 (es) 2009-09-02
KR20100020482A (ko) 2010-02-22
KR101441725B1 (ko) 2014-09-18
EP2937085A1 (en) 2015-10-28
CN101754758A (zh) 2010-06-23
RU2009147456A (ru) 2011-06-27
TWI423802B (zh) 2014-01-21
JP2010527993A (ja) 2010-08-19

Similar Documents

Publication Publication Date Title
AU2008253977B2 (en) A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
US20100160372A1 (en) Treatment of proteinopathies using a farnesyl transferase inhibitor
EP2956443B1 (en) Hydantoins that modulate bace-mediated app processing
JP2010533166A (ja) シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤
US10844071B2 (en) Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau
NZ519797A (en) Treating allergic and inflammatory conditions
HK1215384B (en) A medicament comprising a carbostyril derivative and donezepil for treating alzheimer's disease
HK1140422B (en) A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
KR20230159546A (ko) 신경학적 질환을 치료하기 위한 조성물 및 방법
AU2008225372B2 (en) A medicament for treating chronic obstructive pulmonary disease
KR20250129553A (ko) 바탈라닙을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물
KR20250129556A (ko) Fk960을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물
KR20250129555A (ko) 드로스피레논을 유효성분으로 포함하는 신경 질환 예방 또는 치료용 약학 조성물
JPH08104633A (ja) コリン作動性神経系障害の治療および予防薬
HUT73634A (en) Use of sabeluzole for preparing pharmaceutical compositions againt chronic neurodegenerative diseases
JPWO1998018469A1 (ja) 脳神経細胞保護剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired